ATE395043T1 - Amoxycillin und clavulanat enthaltende pharmazeutische brausefromulierung - Google Patents

Amoxycillin und clavulanat enthaltende pharmazeutische brausefromulierung

Info

Publication number: ATE395043T1
Authority: AT; Austria
Prior art keywords: clavulanate; pharmaceutical; effortable; formulation containing; amoxycillin
Prior art date: 2003-12-12

Application number

AT04820040T

Other languages

English (en)

Inventor

Mathias Scheer

Original Assignee

Cimex Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-12

Filing date

2004-12-10

Publication date

2008-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34486547&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE395043(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-12-10 Application filed by Cimex Ag filed Critical Cimex Ag

2008-05-15 Application granted granted Critical

2008-05-15 Publication of ATE395043T1 publication Critical patent/ATE395043T1/de

Links

HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 title abstract 3
229940090805 clavulanate Drugs 0.000 title abstract 3
HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 title abstract 3
LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 title abstract 2
229960003022 amoxicillin Drugs 0.000 title abstract 2
LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 title abstract 2
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 2
208000035143 Bacterial infection Diseases 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT04820040T 2003-12-12 2004-12-10 Amoxycillin und clavulanat enthaltende pharmazeutische brausefromulierung ATE395043T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03405893A EP1541129A1 (de)	2003-12-12	2003-12-12	Amoxycillin und Clavulanat enthaltende pharmazeutische Brauseformulierung

Publications (1)

Publication Number	Publication Date
ATE395043T1 true ATE395043T1 (de)	2008-05-15

Family

ID=34486547

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04820040T ATE395043T1 (de)	2003-12-12	2004-12-10	Amoxycillin und clavulanat enthaltende pharmazeutische brausefromulierung

Country Status (5)

Country	Link
EP (2)	EP1541129A1 (de)
AT (1)	ATE395043T1 (de)
DE (1)	DE602004013763D1 (de)
ES (1)	ES2307076T3 (de)
WO (1)	WO2005055971A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI21912A (sl) *	2004-12-24	2006-06-30	Lek Farmacevtska Druzba D.D.	Stabilne farmacevtske oblike, ki vsebujejo amoksicilin in klavulansko kislino
DE102006007830A1 (de) *	2006-02-17	2007-08-30	Grünenthal GmbH	Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
EP1887634A3 (de)	2006-08-11	2011-09-07	OSRAM Opto Semiconductors GmbH	Strahlungsemittierendes Halbleiterbauelement
EP2575781A1 (de) *	2010-06-03	2013-04-10	Mahmut Bilgic	Verfahren zur herstellung einer brauseformulierung mit cephalosporin und kalium-clavulanat
EP2809179A4 (de)	2012-02-01	2015-11-18	Intercontinental Great Brands Llc	Kalorienarme getränketablette
WO2014174405A1 (en) *	2013-04-22	2014-10-30	Webb Johannes Arnoldus Vosloo	Pharmaceutical preparation
CN112006994B (zh) *	2020-08-10	2022-10-25	瑞普（天津）生物药业有限公司	一种阿莫西林克拉维酸钾制剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9007945D0 (en) *	1990-04-07	1990-06-06	Beecham Group Plc	Pharmaceutical formulation
AP1806A (en) *	1999-04-13	2007-12-14	Beecham Pharmaceuticals Pte Ltd	The use of a high dosage regimen of amoxycillin and potassium chavulate for the treatment of bacterial infections.

2003
- 2003-12-12 EP EP03405893A patent/EP1541129A1/de not_active Withdrawn
2004
- 2004-12-10 AT AT04820040T patent/ATE395043T1/de active
- 2004-12-10 WO PCT/CH2004/000728 patent/WO2005055971A1/en not_active Ceased
- 2004-12-10 ES ES04820040T patent/ES2307076T3/es not_active Expired - Lifetime
- 2004-12-10 EP EP04820040A patent/EP1622584B1/de not_active Revoked
- 2004-12-10 DE DE602004013763T patent/DE602004013763D1/de not_active Revoked

Also Published As

Publication number	Publication date
EP1622584B1 (de)	2008-05-14
EP1541129A1 (de)	2005-06-15
EP1622584A1 (de)	2006-02-08
DE602004013763D1 (de)	2008-06-26
WO2005055971A1 (en)	2005-06-23
ES2307076T3 (es)	2008-11-16

Similar Documents

Publication	Publication Date	Title
WO2000061116A3 (en)	2001-02-01	Pharmaceutical formulation comprising amoxycillin and clavulanate
WO2000061115A3 (en)	2001-03-01	Pharmaceutical formulation comprising amoxycillin
EP2248519A3 (de)	2011-12-14	Nichtmukoadhäsive Filmdosierungsformen
ATE277594T1 (de)	2004-10-15	Vorrichtungen um eine verlängerte medikamententherapie zu erreichen
BR0215184A (pt)	2006-06-06	composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
MXPA03006476A (es)	2003-09-22	Composiciones farmaceuticas, formas de dosificacion y metodos para administracion oral de epotilonas.
UA84266C2 (uk)	2008-10-10	Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
EA200301165A1 (ru)	2004-06-24	Лекарственное средство на основе оксикодона
AU2002357012A1 (en)	2003-06-10	Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
AU2001227915A1 (en)	2001-07-31	Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
NO20065638L (no)	2007-02-12	Formuleringer med kontrollert frigivelse inneholdende vardenafil
AR034517A1 (es)	2004-02-25	Formulacion farmaceutica
DE50005529D1 (de)	2004-04-08	Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DK1383752T3 (da)	2005-10-17	Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
WO2004032866A3 (en)	2004-07-29	Therapeutic formulations
WO2005044186A3 (en)	2007-03-15	Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
EP1316316A4 (de)	2009-09-09	Zubereitungen zur oralen anwendung
DE60102590T2 (de)	2005-04-21	Darreichungsformen zur behandlung von oralen mykosen
ATE395043T1 (de)	2008-05-15	Amoxycillin und clavulanat enthaltende pharmazeutische brausefromulierung
DE602005008122D1 (de)	2008-08-28	Synergistische antibakterielle Formulierung und Herstellungsmethode
CA2727722A1 (en)	2004-04-22	Use of dihydroimidazolones for the treatment of anxiety in dogs
MY141008A (en)	2010-02-12	Oral formulations of deoxypeganine and their uses
ECSP066965A (es)	2006-12-20	Una composicion farmacéutica antibacterial
PL368040A1 (en)	2005-03-21	Substituted 4-aminocyclohexanol derivatives
NZ542305A (en)	2009-03-31	Treatment of proliferative diseases with an epothilone derivative and radiation

Legal Events

Date

Code

Title

Description

2008-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1622584

Country of ref document: EP

2009-06-15

EEIH

Change in the person of patent owner